JP2011201787A - 2,5-diaminomethyl-bicyclo[2,2,1]heptane and method for producing the same - Google Patents

2,5-diaminomethyl-bicyclo[2,2,1]heptane and method for producing the same Download PDF

Info

Publication number
JP2011201787A
JP2011201787A JP2010068199A JP2010068199A JP2011201787A JP 2011201787 A JP2011201787 A JP 2011201787A JP 2010068199 A JP2010068199 A JP 2010068199A JP 2010068199 A JP2010068199 A JP 2010068199A JP 2011201787 A JP2011201787 A JP 2011201787A
Authority
JP
Japan
Prior art keywords
nbda
bicyclo
heptane
diaminomethyl
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010068199A
Other languages
Japanese (ja)
Other versions
JP5603627B2 (en
Inventor
Tatsunobu Uragami
達宣 浦上
Masaki Okazaki
真喜 岡崎
Kenichi Fukukawa
健一 福川
Wataru Yamashita
渉 山下
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsui Chemicals Inc
Original Assignee
Mitsui Chemicals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsui Chemicals Inc filed Critical Mitsui Chemicals Inc
Priority to JP2010068199A priority Critical patent/JP5603627B2/en
Publication of JP2011201787A publication Critical patent/JP2011201787A/en
Application granted granted Critical
Publication of JP5603627B2 publication Critical patent/JP5603627B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide highly pure 2,5-diaminomethyl-bicyclo[2,2,1]heptane substantially free of isomers, and a method for producing the same.SOLUTION: The 2,5-diaminomethyl-bicyclo[2,2,1]heptane represented by formula (I) or (II) having purity of ≥95% when analyzed by gas chromatography is produced by: protecting amino groups in individual compounds included in an isomer mixture with protective groups; separating the isomers; and deprotecting the protective groups in the separated isomers.

Description

本発明は、高純度の2,5−ジアミノメチル−ビシクロ[2,2,1]ヘプタン、及びその製造方法に関する。   The present invention relates to high-purity 2,5-diaminomethyl-bicyclo [2,2,1] heptane and a method for producing the same.

2,5(又は6)−ジアミノメチル−ビシクロ[2,2,1]ヘプタン(以下、「NBDA」とも記す)は、ポリイミド、ポリアミド等のモノマーとして、またエポキシ樹脂、ビスマレイミド、ジイソシアネート等の原料として、或いはそれらの硬化剤として極めて有用なジアミン化合物である。また、このNBDAを原料に用いることで、光線透過率の良好な(無色透明性の高い)ポリイミドが得られることが知られている(例えば、特許文献1及び2参照)。   2,5 (or 6) -diaminomethyl-bicyclo [2,2,1] heptane (hereinafter also referred to as “NBDA”) is a monomer such as polyimide and polyamide, and a raw material such as epoxy resin, bismaleimide and diisocyanate. Or a diamine compound extremely useful as a curing agent thereof. In addition, it is known that a polyimide having a good light transmittance (highly colorless and transparent) can be obtained by using this NBDA as a raw material (see, for example, Patent Documents 1 and 2).

NBDAは、従来、ビシクロ[2,2,1]−5−ヘプテン−2−カルボニトリルに、パラジウム触媒及びトリフェニルホスファイト、或いは0価ニッケル錯体触媒の存在下でシアン化水素を付加させてジシアノ体とした後、接触水素化することにより製造されている(例えば、特許文献3及び4参照)。このようにして製造されるNBDAには、ビシクロ[2,2,1]ヘプタン環におけるアミノメチル基の置換位置が異なる異性体として、2,5−ジアミノメチル−ビシクロ[2,2,1]ヘプタン(以下、「2,5−NBDA」とも記す)、及び2,6−ジアミノメチル−ビシクロ[2,2,1]ヘプタン(以下、「2,6−NBDA」とも記す)が含まれている。   NBDA has conventionally been prepared by adding hydrogen cyanide to bicyclo [2,2,1] -5-heptene-2-carbonitrile in the presence of a palladium catalyst and triphenyl phosphite or a zerovalent nickel complex catalyst to form a dicyano compound. Then, it is manufactured by catalytic hydrogenation (see, for example, Patent Documents 3 and 4). The NBDA thus produced has 2,5-diaminomethyl-bicyclo [2,2,1] heptane as isomers having different aminomethyl group substitution positions in the bicyclo [2,2,1] heptane ring. (Hereinafter also referred to as “2,5-NBDA”) and 2,6-diaminomethyl-bicyclo [2,2,1] heptane (hereinafter also referred to as “2,6-NBDA”).

これらの異性体は、蒸留等の通常の分離手段では分離することが非常に困難であることが知られている。更に、2,5−NBDAと2,6−NBDAのそれぞれにも光学異性体が存在する。このため、上記のようにして製造されるNBDAは、一般的な分離手段では分離困難な4種類の異性体を含有する異性体混合物である。   These isomers are known to be very difficult to separate by ordinary separation means such as distillation. Furthermore, optical isomers also exist in each of 2,5-NBDA and 2,6-NBDA. For this reason, NBDA produced as described above is an isomer mixture containing four types of isomers that are difficult to separate by general separation means.

NBDAに含まれる4種の異性体を分離する方法として、それぞれの異性体の融点差を利用し、凝固させたNBDAを徐々に昇温させながらそれぞれの異性体が多く含まれる留分に分画する方法が開示されている(例えば、特許文献5参照)。   As a method of separating the four isomers contained in NBDA, the difference in melting point of each isomer is used, and fractionated into fractions rich in each isomer while gradually raising the temperature of the solidified NBDA. Is disclosed (see, for example, Patent Document 5).

特開平10−7906号公報Japanese Patent Laid-Open No. 10-7906 国際公開第1998/029471号International Publication No. 1998/029471 特許第2713612号公報Japanese Patent No. 2713612 特開2002−69043号公報JP 2002-69043 A 国際公開第2002/010253号International Publication No. 2002/010253

特許文献5で開示された異性体の分離方法によると、それぞれの留分に含まれる異性体の量比をある程度制御することは可能であった。しかしながら、他の異性体を実質的に含有しない高純度の化合物を分離精製することは極めて困難であった。   According to the isomer separation method disclosed in Patent Document 5, it was possible to control to some extent the amount ratio of isomers contained in each fraction. However, it has been extremely difficult to separate and purify a high-purity compound substantially free from other isomers.

本発明は、このような従来技術の有する問題点に鑑みてなされたものであり、その課題とするところは、高純度の2,5−ジアミノメチル−ビシクロ[2,2,1]ヘプタン、及びその製造方法を提供することにある。   The present invention has been made in view of such problems of the prior art, and the object of the present invention is high-purity 2,5-diaminomethyl-bicyclo [2,2,1] heptane, and It is in providing the manufacturing method.

本発明者らは上記課題を達成すべく鋭意検討した結果、原材料となるジアミノメチル−ビシクロ[2,2,1]ヘプタンの異性体混合物に含まれるそれぞれの化合物のアミノ基を保護基で保護した後、異性体を分離し、次いで分離した異性体の保護基を脱保護することによって、上記課題を達成することが可能であることを見出し、本発明を完成するに至った。   As a result of intensive studies to achieve the above-mentioned problems, the present inventors have protected the amino group of each compound contained in the isomer mixture of diaminomethyl-bicyclo [2,2,1] heptane as a raw material with a protecting group. Later, it was found that the above-mentioned problems could be achieved by separating the isomers and then deprotecting the protecting groups of the separated isomers, and the present invention was completed.

即ち、本発明によれば、以下に示す2,5−ジアミノメチル−ビシクロ[2,2,1]ヘプタン、及び2,5−ジアミノメチル−ビシクロ[2,2,1]ヘプタンの製造方法が提供される。   That is, according to the present invention, the following methods for producing 2,5-diaminomethyl-bicyclo [2,2,1] heptane and 2,5-diaminomethyl-bicyclo [2,2,1] heptane are provided. Is done.

[1]下記式(I)又は(II)で表される、ガスクロマトグラフィーにより分析される純度が95%以上である2,5−ジアミノメチル−ビシクロ[2,2,1]ヘプタン。   [1] 2,5-diaminomethyl-bicyclo [2,2,1] heptane represented by the following formula (I) or (II) and having a purity analyzed by gas chromatography of 95% or more.

Figure 2011201787
Figure 2011201787

[2]下記式(I)で表される化合物、下記式(II)で表される化合物、下記式(III)で表される化合物、及び下記式(IV)で表される化合物を含むジアミノメチル−ビシクロ[2,2,1]ヘプタンの異性体混合物に含まれるそれぞれの化合物のアミノ基を保護基で保護した後、下記式(I)又は(II)で表される化合物に由来する異性体を結晶化と固液分離を含む分離操作により分離し、次いで分離した前記異性体の前記保護基を脱保護することを含む、下記式(I)又は(II)で表される、ガスクロマトグラフィーにより分析される純度が95%以上である2,5−ジアミノメチル−ビシクロ[2,2,1]ヘプタンの製造方法。   [2] Diamino containing a compound represented by the following formula (I), a compound represented by the following formula (II), a compound represented by the following formula (III), and a compound represented by the following formula (IV) After protecting the amino group of each compound contained in the isomer mixture of methyl-bicyclo [2,2,1] heptane with a protecting group, isomers derived from the compound represented by the following formula (I) or (II) Gas chromatography represented by the following formula (I) or (II), which comprises separating the product by a separation operation including crystallization and solid-liquid separation, and then deprotecting the protecting group of the separated isomer A method for producing 2,5-diaminomethyl-bicyclo [2,2,1] heptane having a purity analyzed by chromatography of 95% or more.

Figure 2011201787
Figure 2011201787

[3]前記保護基が、フタルイミド基、t−ブチルオキシカルボニル基、又はベンジルオキシカルボニル基である、前記[2]に記載の製造方法。   [3] The production method according to [2], wherein the protective group is a phthalimide group, a t-butyloxycarbonyl group, or a benzyloxycarbonyl group.

本発明の2,5−ジアミノメチル−ビシクロ[2,2,1]ヘプタンは、ガスクロマトグラフィーにより分析される純度が95%以上の、異性体を実質的に含有しない高純度な化合物であり、各種の樹脂材料や化成品の原料として、特に、電子部品の構成材料として用いられるポリイミドフィルムを形成するための原料として極めて有用である。   The 2,5-diaminomethyl-bicyclo [2,2,1] heptane of the present invention is a high-purity compound that has a purity of 95% or more analyzed by gas chromatography and substantially does not contain an isomer, As a raw material for various resin materials and chemical products, it is particularly useful as a raw material for forming a polyimide film used as a constituent material for electronic parts.

本発明の製造方法によれば、ガスクロマトグラフィーにより分析される純度が95%以上の、異性体を実質的に含有しない高純度な2,5−ジアミノメチル−ビシクロ[2,2,1]ヘプタンを、工業的にも適用可能な簡便な操作で製造することができる。   According to the production method of the present invention, high-purity 2,5-diaminomethyl-bicyclo [2,2,1] heptane having a purity analyzed by gas chromatography of 95% or more and substantially free of isomers Can be produced by a simple operation that can be applied industrially.

実施例1で得られた2,5−diexo−ビスフタルイミドメチル−ビシクロ[2,2,1]ヘプタンの13C−NMRチャートである。2 is a 13 C-NMR chart of 2,5-diexo-bisphthalimidomethyl-bicyclo [2,2,1] heptane obtained in Example 1. FIG. 実施例1で得られた2,5−diexo−ジアミノメチル−ビシクロ[2,2,1]ヘプタンの13C−NMRチャートである。2 is a 13 C-NMR chart of 2,5-diexo-diaminomethyl-bicyclo [2,2,1] heptane obtained in Example 1. FIG. 原材料であるジアミノメチル−ビシクロ[2,2,1]ヘプタンのガスクロマトグラフィー(GC)チャートである。It is a gas chromatography (GC) chart of diaminomethyl-bicyclo [2,2,1] heptane as a raw material. 実施例1で得られた2,5−diexo−ジアミノメチル−ビシクロ[2,2,1]ヘプタンのガスクロマトグラフィー(GC)チャートである。2 is a gas chromatography (GC) chart of 2,5-diexo-diaminomethyl-bicyclo [2,2,1] heptane obtained in Example 1. FIG. 実施例2で得られた2−endo−5−exo−ビスフタルイミドメチル−ビシクロ[2,2,1]ヘプタンの13C−NMRチャートである。2 is a 13 C-NMR chart of 2-endo-5-exo-bisphthalimidomethyl-bicyclo [2,2,1] heptane obtained in Example 2. FIG. 実施例2で得られた2−endo−5−exo−ジアミノメチル−ビシクロ[2,2,1]ヘプタンの13C−NMRチャートである。2 is a 13 C-NMR chart of 2-endo-5-exo-diaminomethyl-bicyclo [2,2,1] heptane obtained in Example 2. FIG. 実施例2で得られた2−endo−5−exo−ジアミノメチル−ビシクロ[2,2,1]ヘプタンのガスクロマトグラフィー(GC)チャートである。2 is a gas chromatography (GC) chart of 2-endo-5-exo-diaminomethyl-bicyclo [2,2,1] heptane obtained in Example 2. FIG.

以下、本発明の実施の形態について説明するが、本発明は以下の実施の形態に限定されるものではない。   Embodiments of the present invention will be described below, but the present invention is not limited to the following embodiments.

[1]2,5−ジアミノメチル−ビシクロ[2,2,1]ヘプタン:
本発明の2,5−ジアミノメチル−ビシクロ[2,2,1]ヘプタン(以下、「2,5−NBDA」とも記す)は、下記式(I)又は(II)で表されるジアミン化合物である。なお、下記式(I)で表されるジアミン化合物は、2,5−diexo−ジアミノメチル−ビシクロ[2,2,1]ヘプタン(以下、「2,5−diexo−NBDA」とも記す)である。また、下記式(II)で表されるジアミン化合物は、2−endo−5−exo−ジアミノメチル−ビシクロ[2,2,1]ヘプタン(以下、「2−endo−5−exo−NBDA」とも記す)である。
[1] 2,5-Diaminomethyl-bicyclo [2,2,1] heptane:
2,5-Diaminomethyl-bicyclo [2,2,1] heptane (hereinafter also referred to as “2,5-NBDA”) of the present invention is a diamine compound represented by the following formula (I) or (II). is there. The diamine compound represented by the following formula (I) is 2,5-diexo-diaminomethyl-bicyclo [2,2,1] heptane (hereinafter also referred to as “2,5-diexo-NBDA”). . Further, the diamine compound represented by the following formula (II) is 2-endo-5-exo-diaminomethyl-bicyclo [2,2,1] heptane (hereinafter referred to as “2-endo-5-exo-NBDA”). It is noted).

Figure 2011201787
Figure 2011201787

前記式(I)で表される2,5−diexo−NBDA、及び前記式(II)で表される2−endo−5−exo−NBDAは、いずれも他の異性体を実質的に含有せず、純度の高いものである。より具体的には、ガスクロマトグラフィー(GC)により分析して得られるチャートの領域面積に基づき算出される2,5−diexo−NBDA及び2−endo−5−exo−NBDAの純度は、いずれも95%以上、好ましくは97.0%以上、更に好ましくは99.0%以上、特に好ましくは100%のものである。   The 2,5-diexo-NBDA represented by the formula (I) and the 2-endo-5-exo-NBDA represented by the formula (II) are substantially free of other isomers. However, it is highly pure. More specifically, the purity of 2,5-diexo-NBDA and 2-endo-5-exo-NBDA calculated based on the area of the chart obtained by analysis by gas chromatography (GC) is both It is 95% or more, preferably 97.0% or more, more preferably 99.0% or more, and particularly preferably 100%.

本発明の2,5−NBDAは、他の異性体を実質的に含有しない、これまでにない高純度のジアミン化合物である。このため、各種の樹脂材料や化成品の原料、或いは電気・電子材料、光学材料、塗料・接着剤材料、構造部材、断熱材等としての用途が期待されるが、特に、電子部品の構成材料として用いられるポリイミドフィルムを形成するための原料として有用である。   2,5-NBDA of the present invention is an unprecedented high-purity diamine compound that is substantially free of other isomers. For this reason, it is expected to be used as a raw material for various resin materials and chemical products, or electric / electronic materials, optical materials, paint / adhesive materials, structural members, heat insulating materials, etc. It is useful as a raw material for forming a polyimide film used as the above.

[2]2,5−ジアミノメチル−ビシクロ[2,2,1]ヘプタンの製造方法:
本発明の2,5−NBDAの製造方法は、NBDAに含まれるそれぞれの化合物のアミノ基を保護基で保護した後、2,5−NBDAに由来する異性体を結晶化と固液分離を含む分離操作により分離し、次いで分離した異性体の保護基を脱保護することを含む製造方法である。NBDAに含まれる化合物のアミノ基を保護基で保護して得られるそれぞれの化合物どうしの結晶性の差異は、保護する前の化合物どうしの結晶性の差異に比して大きくなる。即ち、本発明の製造方法によれば、アミノ基を保護することにより、異性体どうしを工業的にも十分実用化が可能な簡便な結晶化及び固液分離を含む分離操作により分離することができる。
[2] Method for producing 2,5-diaminomethyl-bicyclo [2,2,1] heptane:
The method for producing 2,5-NBDA of the present invention includes crystallization and solid-liquid separation of isomers derived from 2,5-NBDA after protecting the amino group of each compound contained in NBDA with a protecting group. It is a production method including separation by a separation operation and then deprotecting the protecting group of the separated isomer. The difference in crystallinity between compounds obtained by protecting the amino group of a compound contained in NBDA with a protecting group is larger than the difference in crystallinity between compounds before protection. That is, according to the production method of the present invention, by protecting amino groups, isomers can be separated by a separation operation including simple crystallization and solid-liquid separation that can be sufficiently put into practical use industrially. it can.

NBDAは、下記式(I)で表される2,5−diexo−NBDA、下記式(II)で表される2−endo−5−exo−NBDA、下記式(III)で表される2−exo−6−exo−ジアミノメチル−ビシクロ[2,2,1]ヘプタン(以下、「2,6−diexo−NBDA」ともいう)、及び下記式(IV)で表される2−endo−6−exo−ジアミノメチル−ビシクロ[2,2,1]ヘプタン(「2−endo−6−exo−NBDA」とも記す)を含有する異性体混合物である。   NBDA includes 2,5-diexo-NBDA represented by the following formula (I), 2-endo-5-exo-NBDA represented by the following formula (II), and 2- exo-6-exo-diaminomethyl-bicyclo [2,2,1] heptane (hereinafter also referred to as “2,6-diexo-NBDA”) and 2-endo-6-6 represented by the following formula (IV) An isomeric mixture containing exo-diaminomethyl-bicyclo [2,2,1] heptane (also referred to as “2-endo-6-exo-NBDA”).

Figure 2011201787
Figure 2011201787

[2−1]NBDA:
原料となる異性体混合物であるNBDAとしては、従来公知の方法に従って製造されたものを用いることができる。具体的には、ビシクロ[2,2,1]−5−ヘプテン−2−カルボニトリルに、パラジウム触媒及びトリフェニルホスファイト、或いは0価ニッケル錯体触媒の存在下でシアン化水素を付加させてジシアノ体とした後、接触水素化することにより製造されたもの等を用いることができる。また、市販品としては三井化学社製の商品名「NBDA」がある。これらのNBDAには、通常、2,5−diexo−NBDAが約26質量%、2−endo−5−exo−NBDAが約36質量%、2,6−diexo−NBDAが約20質量%、及び2−endo−6−exo−NBDAが約18質量%の割合で含有されている。
[2-1] NBDA:
As NBDA which is a mixture of isomers as a raw material, those produced according to a conventionally known method can be used. Specifically, hydrogen cyanide is added to bicyclo [2,2,1] -5-heptene-2-carbonitrile in the presence of a palladium catalyst and triphenyl phosphite or a zero-valent nickel complex catalyst to form a dicyano compound. After that, those produced by catalytic hydrogenation can be used. As a commercially available product, there is a trade name “NBDA” manufactured by Mitsui Chemicals. These NBDAs are typically about 26% by weight of 2,5-diexo-NBDA, about 36% by weight of 2-endo-5-exo-NBDA, about 20% by weight of 2,6-diexo-NBDA, and 2-endo-6-exo-NBDA is contained at a ratio of about 18% by mass.

[2−2]アミノ基の保護:
先ず、NBDAに含まれるそれぞれの化合物のアミノ基を保護基により保護する。保護基の種類は特に限定されず、1級のアミノ基を保護することが可能な保護基であればよい。但し、試薬の取り扱い性や、保護された化合物(異性体)をそれらの結晶性の相違に基づいて分離する際の分離性の観点からは、フタルイミド基、t−ブチルオキシカルボニル基(t−BOC基)、又はベンジルオキシカルボニル基(Z−基)が好ましい。なお、アミノ基の保護基をフタルイミド基とした場合には、保護された異性体どうしの結晶性の差が大きくなるため、結晶化と固液分離により異性体をより簡便に分離しやすくなるために好ましい。
[2-2] Protection of amino group:
First, the amino group of each compound contained in NBDA is protected with a protecting group. The kind of the protecting group is not particularly limited as long as it is a protecting group capable of protecting the primary amino group. However, from the viewpoint of the handleability of reagents and the separability when separating protected compounds (isomers) based on their crystallinity differences, phthalimide groups, t-butyloxycarbonyl groups (t-BOC) Group) or a benzyloxycarbonyl group (Z-group) is preferable. In addition, when the protecting group of the amino group is a phthalimide group, the difference in crystallinity between the protected isomers increases, so that it becomes easier to separate the isomers by crystallization and solid-liquid separation. Is preferable.

[2−3]異性体の分離:
次に、保護基によってアミノ基が保護された異性体のうち、2,5−diexo−NBDA及び2−endo−5−exo−NBDAに由来する異性体を、結晶化と固液分離を含む分離操作によりそれぞれ分離する。保護基の種類がフタルイミド基、t−BOC基、及びZ−基である場合を例に挙げると、下記式(I−1)〜(I−3)、及び下記式(II−1)〜(II−3)で表される異性体をそれぞれ分離する。
[2-3] Isomeric separation:
Next, among isomers whose amino group is protected by a protecting group, isomers derived from 2,5-diexo-NBDA and 2-endo-5-exo-NBDA are separated including crystallization and solid-liquid separation. Separate by operation. Taking the case where the type of protecting group is a phthalimide group, a t-BOC group, and a Z-group as examples, the following formulas (I-1) to (I-3) and the following formulas (II-1) to ( The isomers represented by II-3) are separated.

Figure 2011201787
Figure 2011201787

Figure 2011201787
Figure 2011201787

例えば、各種溶媒を用いた固液分離や再結晶を行うこと等により、アミノ基が保護された異性体を分離することができる。このとき、用いる溶媒の種類や温度等を適宜選択・設定することにより、2,5−diexo−NBDAに由来する異性体のみを実質的に含有する分画や、2−endo−5−exo−NBDAに由来する異性体のみを実質的に含有する分画を得ることができる。   For example, isomers with amino groups protected can be separated by performing solid-liquid separation or recrystallization using various solvents. At this time, by appropriately selecting and setting the type and temperature of the solvent to be used, a fraction containing substantially only an isomer derived from 2,5-diexo-NBDA, or 2-endo-5-exo- A fraction containing substantially only the isomer derived from NBDA can be obtained.

[2−4]脱保護:
分離した異性体の保護基を脱保護することにより、目的とする2,5−diexo−NBDA及び2−endo−5−exo−NBDAを得ることができる。保護基は、保護基の種類に応じて従来公知の方法に従って脱保護することができる。例えば、保護基がフタルイミド基である場合には、ヒドラジン等で処理することで脱保護することができる。保護基がt−BOC基である場合には、トリフルオロ酢酸等で処理することで脱保護することができる。また、保護基がZ−基である場合には、パラジウム触媒の存在下に水素添加すること等で脱保護することができる。
[2-4] Deprotection:
The desired 2,5-diexo-NBDA and 2-endo-5-exo-NBDA can be obtained by deprotecting the protecting groups of the separated isomers. The protecting group can be deprotected according to a conventionally known method depending on the kind of the protecting group. For example, when the protecting group is a phthalimide group, it can be deprotected by treatment with hydrazine or the like. When the protecting group is a t-BOC group, it can be deprotected by treatment with trifluoroacetic acid or the like. Further, when the protecting group is a Z-group, it can be deprotected by hydrogenation in the presence of a palladium catalyst.

なお、保護基を脱保護した後、必要に応じて精製して目的とする2,5−diexo−NBDA及び2−endo−5−exo−NBDAの純度を高めることが好ましい。精製方法は特に限定されないが、好適例として減圧蒸留、カラムによる分離、再結晶等の方法を挙げることができる。   In addition, after deprotecting a protecting group, it is preferable to refine | purify as needed and to raise the purity of the target 2, 5- diexo-NBDA and 2-endo-5-exo-NBDA. The purification method is not particularly limited, and preferred examples include vacuum distillation, column separation, recrystallization, and the like.

このようにして得られる2,5−diexo−NBDA及び2−endo−5−exo−NBDAのガスクロマトグラフィーにより分析される純度は、いずれも95%以上である。なお、純度100%の2,5−diexo−NBDA及び2−endo−5−exo−NBDAは、常温・常圧下でいずれも液状(オイル状)である。   The purity of the thus obtained 2,5-diexo-NBDA and 2-endo-5-exo-NBDA analyzed by gas chromatography is 95% or more. Note that 2,5-diexo-NBDA and 2-endo-5-exo-NBDA having a purity of 100% are both liquid (oil-like) at normal temperature and normal pressure.

[2−5]2,5−NBDAの製造:
以下、保護基の種類がフタルイミド基である場合を例に挙げ、2,5−NBDAの製造方法の更なる詳細について説明する。先ず、原料となるNBDAと無水フタル酸を、p−トルエンスルホン酸等の適当な触媒の存在下、有機溶媒中で加熱して脱水縮合させる。有機溶媒の具体例としては、トルエン、DMF等を挙げることができる。なお、系外に水分を排出しながら反応させることが好ましい。
[2-5] Production of 2,5-NBDA:
Hereafter, the case where the kind of protecting group is a phthalimide group is mentioned as an example, and the further detail of the manufacturing method of 2, 5-NBDA is demonstrated. First, NBDA and phthalic anhydride as raw materials are dehydrated and condensed by heating in an organic solvent in the presence of a suitable catalyst such as p-toluenesulfonic acid. Specific examples of the organic solvent include toluene and DMF. The reaction is preferably performed while draining water out of the system.

[2−5−1]2,5−diexo−NBDAの製造:
NBDAと無水フタル酸の反応が終了した後、室温(25℃)まで冷却し、析出した結晶を濾取する。得られた結晶を、適当な有機溶媒を使用して再結晶するか、或いは有機溶媒中に分散させたスラリーを加熱するスラッジング処理を行うことによって精製することが好ましい。再結晶及びスラッジング処理に用いる有機溶媒の具体例としては、トルエン、アセトニトリル、キシレン、メチルセロソルブ、酢酸エチル等を挙げることができる。再結晶及び/又はスラッジング処理による精製を好ましくは2回以上行うことによって、前記式(I−1)で表される異性体を得ることができる。
[2-5-1] Production of 2,5-diexo-NBDA:
After the reaction between NBDA and phthalic anhydride is completed, the mixture is cooled to room temperature (25 ° C.), and the precipitated crystals are collected by filtration. The obtained crystals are preferably recrystallized using an appropriate organic solvent or purified by a sludge treatment in which a slurry dispersed in the organic solvent is heated. Specific examples of the organic solvent used for the recrystallization and sludge treatment include toluene, acetonitrile, xylene, methyl cellosolve, ethyl acetate and the like. The isomer represented by the formula (I-1) can be obtained by performing purification by recrystallization and / or sludge treatment preferably twice or more.

次に、前記式(I−1)で表される異性体を、イソプロピルアルコール、メタノール、メチルセロソルブ等の溶媒中、加熱条件下でヒドラジン一水和物と反応させると、2,5−diexo−NBDAのフタラジンジオン塩が反応系中に析出する。濾過して取り出した2,5−diexo−NBDAのフタラジンジオン塩を塩酸等の酸で処理して酸分解した後、水酸化ナトリウム等の塩基で中和すれば、2,5−diexo−NBDAの粗生成物を得ることができる。その後、有機溶媒による抽出、及び減圧蒸留すること等によって精製すれば、目的とする高純度の2,5−diexo−NBDAを得ることができる。   Next, when the isomer represented by the formula (I-1) is reacted with hydrazine monohydrate under a heating condition in a solvent such as isopropyl alcohol, methanol, methyl cellosolve, etc., 2,5-diexo- NBDA phthalazinedione salt precipitates in the reaction system. 2,5-diexo-NBDA is obtained by treating the phthalazinedione salt of 2,5-diexo-NBDA with an acid such as hydrochloric acid and then neutralizing it with a base such as sodium hydroxide. The crude product can be obtained. Then, if it refine | purifies by extraction by an organic solvent, distillation under reduced pressure, etc., the target highly purified 2, 5- diexo-NBDA can be obtained.

[2−5−2]2−endo−5−exo−NBDAの製造:
NBDAと無水フタル酸の反応が終了した後、室温(25℃)まで冷却し、析出した結晶を濾別して濾液を得る。得られた濾液を水中に徐々に投入し、析出した結晶を濾取する。得られた結晶を乾燥した後、100℃前後に加熱した有機溶媒に溶解させる。有機溶媒としてはトルエン、キシレン、メシチレン、メチルセロソルブ、メチルエチルケトン等を用いることができるが、なかでもトルエンが好ましい。結晶を有機溶媒に溶解させて得られた溶液を室温(25℃)まで冷却し、析出した結晶を濾別する。得られた濾液を加熱条件下で濃縮した後、好ましくは0〜50℃に冷却して析出した結晶を濾取する。得られた結晶を、必要に応じてDMF等の有機溶媒を用いて再結晶することにより、前記式(II−1)で表される異性体を得ることができる。
[2-5-2] Production of 2-endo-5-exo-NBDA:
After the reaction between NBDA and phthalic anhydride is completed, the mixture is cooled to room temperature (25 ° C.), and the precipitated crystals are separated by filtration to obtain a filtrate. The obtained filtrate is gradually poured into water, and the precipitated crystals are collected by filtration. The obtained crystals are dried and then dissolved in an organic solvent heated to around 100 ° C. As the organic solvent, toluene, xylene, mesitylene, methyl cellosolve, methyl ethyl ketone and the like can be used, and among these, toluene is preferable. A solution obtained by dissolving crystals in an organic solvent is cooled to room temperature (25 ° C.), and the precipitated crystals are separated by filtration. After concentrating the obtained filtrate under heating conditions, it is preferably cooled to 0 to 50 ° C., and the precipitated crystals are collected by filtration. By recrystallizing the obtained crystal using an organic solvent such as DMF as necessary, an isomer represented by the formula (II-1) can be obtained.

次に、前記式(II−1)で表される異性体を、イソプロピルアルコール、メタノール、メチルセロソルブ等の溶媒中、加熱条件下でヒドラジン一水和物と反応させ、アミノ基を保護する保護基を脱保護する。生成したフタラジンジオンの結晶を濾別した後、濾液を濃縮すれば2−endo−5−exo−NBDAの粗生成物を得ることができる。その後、減圧蒸留すること等によって精製すれば、目的とする高純度の2−endo−5−exo−NBDAを得ることができる。   Next, the isomer represented by the formula (II-1) is reacted with hydrazine monohydrate under a heating condition in a solvent such as isopropyl alcohol, methanol, methyl cellosolve, and the like, thereby protecting the amino group. Deprotect. After the produced phthalazinedione crystals are filtered off, the filtrate is concentrated to obtain a crude product of 2-endo-5-exo-NBDA. Then, if it refine | purifies by vacuum distillation etc., the target high purity 2-endo-5-exo-NBDA can be obtained.

以下、本発明を実施例に基づいて具体的に説明するが、本発明はこれらの実施例に限定されるものではない。   EXAMPLES Hereinafter, although this invention is demonstrated concretely based on an Example, this invention is not limited to these Examples.

(実施例1:2,5−diexo−NBDAの製造)
(1)アミノ基の保護(フタルイミド化):
撹拌装置、滴下漏斗、温度計、コンデンサー、窒素導入管、及びディーンスターク水分離器を備え付けた300mlガラス製反応装置に、無水フタル酸325.9g(2.2mol)、p−トルエンスルホン酸0.75g、N,N−ジメチルホルムアミド1250g、及びトルエン250gを装入し、窒素雰囲気下において撹拌しながら140℃へ昇温した。トルエン還流下において140〜145℃を維持しながら、4種の異性体混合物である、ジアミノメチル−ビシクロ[2,2,1]ヘプタン(商品名:NBDA、三井化学社製)154.3g(1.0mol)、及びN,N−ジメチルホルムアミド154.3gの混合溶液を、90分かけて徐々に滴下した。途中反応により生成する水はトルエンとの共沸によりディーンスターク水分離器により系外へ排出し、トルエンは系内へ戻した。滴下終了後、同温度を6時間維持して充分に反応を進行させた後、放冷により室温まで冷却し、析出した白色結晶を濾取した。なお、NBDAのアミノ基をフタルイミド化する際の反応式を以下に示す。
(Example 1: Production of 2,5-diexo-NBDA)
(1) Protection of amino group (phthalimidation):
In a 300 ml glass reactor equipped with a stirrer, dropping funnel, thermometer, condenser, nitrogen inlet tube, and Dean-Stark water separator, 325.9 g (2.2 mol) of phthalic anhydride, p-toluenesulfonic acid 0.8. 75 g, N, N-dimethylformamide 1250 g, and toluene 250 g were charged, and the temperature was raised to 140 ° C. with stirring in a nitrogen atmosphere. While maintaining 140 to 145 ° C. under reflux of toluene, 154.3 g (1 name: diaminomethyl-bicyclo [2,2,1] heptane (trade name: NBDA, manufactured by Mitsui Chemicals), which is a mixture of four isomers 0.0 mol) and a mixed solution of N, N-dimethylformamide 154.3 g were gradually added dropwise over 90 minutes. The water produced during the reaction was discharged out of the system by a Dean-Stark water separator by azeotropy with toluene, and toluene was returned to the system. After completion of the dropping, the temperature was maintained for 6 hours and the reaction was allowed to proceed sufficiently. Then, the mixture was allowed to cool to room temperature, and the precipitated white crystals were collected by filtration. The reaction formula for phthalimidating the amino group of NBDA is shown below.

Figure 2011201787
Figure 2011201787

得られた白色結晶をHPLCで分析したところ、83.7面積%の主成分を含む混合物であることが判明した。なお、収量は97.5gであった。一方、濾液(以下、「濾液A」と記す)をHPLCで分析したところ、この濾液Aには、3種の主生成物、及び上記白色結晶と同様の保持時間で溶出するピークを含む極僅かな混合物が含まれていることが判明した。   The obtained white crystals were analyzed by HPLC and found to be a mixture containing 83.7 area% of the main component. The yield was 97.5 g. On the other hand, when the filtrate (hereinafter referred to as “filtrate A”) was analyzed by HPLC, this filtrate A contained a very small amount of three main products and a peak that eluted at the same retention time as the white crystals. It was found that the mixture was contained.

得られた白色結晶を400gのアセトニトリル中に分散させてスラリー状態とし、スラリー状態のまま加熱して30分間還流した。室温まで冷却した後、85.0gの白色結晶を得た。HPLCで分析した得られた白色結晶の純度(領域面積に基づく)は97.3%であった。得られた白色結晶を450gのトルエン中に分散させてスラリー状態とし、スラリー状態のまま加熱して70℃で1時間スラッジングした後、60〜65℃で熱濾過することで白色結晶を得た。HPLCで分析した得られた白色結晶の純度(領域面積に基づく)は100.0%であり、収量は73.0gであり、NBDAからの収率は17.6%であった。また、得られた白色結晶の13C−NMRチャートを図1に示す。図1に示す13C−NMRチャートから、得られた白色結晶は前記式(I−1)で表される2,5−diexo−ビスフタルイミドメチル−ビシクロ[2,2,1]ヘプタンであることが判明した。なお、13C−NMRは、日本電子社製の「ECA500」(500MHz)を使用し、重クロロホルムを溶媒として用いて測定した。 The obtained white crystals were dispersed in 400 g of acetonitrile to form a slurry, heated in the slurry state and refluxed for 30 minutes. After cooling to room temperature, 85.0 g of white crystals were obtained. The purity (based on area area) of the resulting white crystals analyzed by HPLC was 97.3%. The obtained white crystals were dispersed in 450 g of toluene to form a slurry, heated in the slurry state and sludged at 70 ° C. for 1 hour, and then hot filtered at 60 to 65 ° C. to obtain white crystals. . The purity (based on area area) of the resulting white crystals analyzed by HPLC was 100.0%, the yield was 73.0 g, and the yield from NBDA was 17.6%. Moreover, the 13 C-NMR chart of the obtained white crystal is shown in FIG. From the 13 C-NMR chart shown in FIG. 1, the obtained white crystal is 2,5-diexo-bisphthalimidomethyl-bicyclo [2,2,1] heptane represented by the formula (I-1). There was found. 13 C-NMR was measured using “ECA500” (500 MHz) manufactured by JEOL Ltd. and deuterated chloroform as a solvent.

(2)脱保護:
撹拌装置、温度計、温度計、窒素導入管、及びコンデンサーを備え付けた1000mlガラス製反応装置に、上記(1)の操作を繰り返し行って得られた2,5−diexo−ビスフタルイミドメチル−ビシクロ[2,2,1]ヘプタン124.4g(0.3mol)及びイソプロピルアルコール1200gを装入し、撹拌しながら60℃まで加熱した。同温度を維持しながら96%ヒドラジン(1水和物)90.0g(1.8mol)を1時間かけて滴下した。同温度を維持しながら更に3時間撹拌して反応を完結させた。なお、HPLCで2,5−diexo−ビスフタルイミドメチル−ビシクロ[2,2,1]ヘプタンの消失を確認することにより、反応の完結(終点)を確認した。反応終了後、室温まで冷却し、析出した2,5−diexo−NBDAのフタラジンジオン塩(以下単に「フタラジンジオン塩」と記す)を濾過して単離した。
(2) Deprotection:
2,5-diexo-bisphthalimidomethyl-bicyclo obtained by repeating the above operation (1) in a 1000 ml glass reactor equipped with a stirrer, thermometer, thermometer, nitrogen inlet tube and condenser. 2,2,1] heptane 124.4 g (0.3 mol) and isopropyl alcohol 1200 g were charged and heated to 60 ° C. with stirring. While maintaining the same temperature, 90.0 g (1.8 mol) of 96% hydrazine (monohydrate) was added dropwise over 1 hour. The mixture was further stirred for 3 hours while maintaining the same temperature to complete the reaction. The completion (end point) of the reaction was confirmed by confirming the disappearance of 2,5-diexo-bisphthalimidomethyl-bicyclo [2,2,1] heptane by HPLC. After completion of the reaction, the reaction mixture was cooled to room temperature, and the precipitated phthalazine dione salt of 2,5-diexo-NBDA (hereinafter simply referred to as “phthalazine dione salt”) was isolated by filtration.

撹拌装置、温度計、及び滴下漏斗を備え付けた3000mlガラス製反応装置に単離したフタラジンジオン塩を装入し、水340gを加えて撹拌してスラリー状態とした。撹拌しながら14.2質量%塩化水素水溶液840g(3.26mol)を1時間かけて滴下し、塩を酸分解して2,5−diexo−NBDA塩酸塩とした。続けて30質量%水酸化ナトリウム水溶液520.8gを1時間かけて滴下し、2,5−diexo−NBDA塩酸塩を中和した後、固形分を濾過した。ロータリーエバポレーターを使用して濾液を濃縮し、塩化ナトリウム、フタラジンジオン、少量の水酸化ナトリウム、及び2,5−diexo−NBDAを含む淡黄色の塊状物を得た。なお、フタルイミド基を脱保護する際の反応式を以下に示す。   The isolated phthalazinedione salt was charged into a 3000 ml glass reactor equipped with a stirrer, a thermometer, and a dropping funnel, and 340 g of water was added and stirred to form a slurry. While stirring, 840 g (3.26 mol) of a 14.2 mass% hydrogen chloride aqueous solution was added dropwise over 1 hour, and the salt was acid-decomposed to give 2,5-diexo-NBDA hydrochloride. Subsequently, 520.8 g of a 30% by mass aqueous sodium hydroxide solution was added dropwise over 1 hour to neutralize 2,5-diexo-NBDA hydrochloride, and then the solid content was filtered. The filtrate was concentrated using a rotary evaporator to give a pale yellow mass containing sodium chloride, phthalazinedione, a small amount of sodium hydroxide, and 2,5-diexo-NBDA. The reaction formula for deprotecting the phthalimide group is shown below.

Figure 2011201787
Figure 2011201787

得られた塊状物にトルエン600gを添加してよく撹拌し、目的物である2,5−diexo−NBDAをトルエンに溶解させた。固形分を濾別した後、ロータリーエバポレーターを使用して濾液を濃縮し、少量のトルエンを含む41.5gの淡黄色液体を得た。得られた液体について170〜175℃に加熱された油浴中、2.8〜3.5kPaの減圧度で減圧蒸留を行ったところ、無色透明の2,5−diexo−NBDA30.2gを得た。ガスクロマトグラフィーにより分析した2,5−diexo−NBDAの純度は100%であり、2,5−diexo−ビスフタルイミドメチル−ビシクロ[2,2,1]ヘプタンからの収率は65.3%であった。また、DSCにより融点を測定しようとしたところ−20℃においても結晶化しなかった。得られた2,5−diexo−NBDAの13C−NMRチャートを図2に示す。また、原材料であるNBDA及び得られた2,5−diexo−NBDAのガスクロマトグラフィー(GC)チャートを図3及び4にそれぞれ示す。なお、ガスクロマトグラフィーの条件を以下に示す。 To the obtained mass, 600 g of toluene was added and stirred well, and the target product, 2,5-diexo-NBDA, was dissolved in toluene. After filtering off the solid content, the filtrate was concentrated using a rotary evaporator to obtain 41.5 g of a pale yellow liquid containing a small amount of toluene. When the obtained liquid was distilled under reduced pressure at a reduced pressure of 2.8 to 3.5 kPa in an oil bath heated to 170 to 175 ° C., 30.2 g of colorless and transparent 2,5-diexo-NBDA was obtained. . The purity of 2,5-diexo-NBDA analyzed by gas chromatography was 100%, and the yield from 2,5-diexo-bisphthalimidomethyl-bicyclo [2,2,1] heptane was 65.3%. there were. Further, when the melting point was measured by DSC, it did not crystallize even at -20 ° C. FIG. 2 shows a 13 C-NMR chart of the obtained 2,5-diexo-NBDA. Moreover, the gas chromatography (GC) chart of NBDA which is a raw material, and the obtained 2, 5- diexo-NBDA is shown to FIG. 3 and 4, respectively. The conditions for gas chromatography are shown below.

カラム種類:無極性カラム、商品名「ZB−1」、Phenomenex社製
カラムサイズ:内径×長さ×膜厚=0.53mm×30m×3μm
キャリアーガス:ヘリウム
カラム圧力:定圧モード20kPa
カラム温度:160℃
試料気化室及び検出部温度:280℃
Column type: nonpolar column, trade name “ZB-1”, manufactured by Phenomenex Co., Ltd. Column size: inner diameter × length × film thickness = 0.53 mm × 30 m × 3 μm
Carrier gas: Helium Column pressure: Constant pressure mode 20 kPa
Column temperature: 160 ° C
Sample vaporization chamber and detector temperature: 280 ° C

(実施例2:2−endo−5−exo−NBDAの製造)
(3)アミノ基の保護(フタルイミド化):
撹拌装置、滴下漏斗、及び温度計を備え付け、水3500gを装入したガラス製反応装置に、上記実施例1における(1)の操作で得られた濾液Aを30分かけて滴下し、結晶を析出させた。析出した結晶を濾別及び乾燥した後、100℃に加熱した800gのトルエンに溶解した。得られた溶液を放冷し、室温(25℃)まで冷却して生じた結晶を濾別した。ロータリーエバポレーターを使用し、約400mlになるまで濾液を濃縮した。濃縮した濾液を放冷したところ徐々に白色結晶が析出した。50℃まで冷却したところで濾過し、85.0gの白色結晶を得た。得られた白色結晶をHPLCで分析したところ、88.4面積%の主成分を含む混合物であることが判明した。この混合物(白色結晶)の全量を420gのN,N−ジメチルホルムアミドに溶解させて再結晶を行い、56.0gの白色結晶を得た。HPLCで分析した得られた白色結晶の純度(領域面積に基づく)は100.0%であり、NBDAからの収率は9.0%であった。また、得られた白色結晶の13C−NMRチャートを図5に示す。図5に示す13C−NMRチャートから、得られた白色結晶は前記式(II−1)で表される2−endo−5−exo−ビスフタルイミドメチル−ビシクロ[2,2,1]ヘプタンであることが判明した。
(Example 2: Production of 2-endo-5-exo-NBDA)
(3) Protection of amino group (phthalimidation):
The filtrate A obtained by the operation of (1) in Example 1 was dropped over 30 minutes into a glass reactor equipped with a stirrer, a dropping funnel, and a thermometer and charged with 3500 g of water, and crystals were obtained. Precipitated. The precipitated crystals were separated by filtration and dried, and then dissolved in 800 g of toluene heated to 100 ° C. The resulting solution was allowed to cool, cooled to room temperature (25 ° C.), and the resulting crystals were filtered off. Using a rotary evaporator, the filtrate was concentrated to about 400 ml. When the concentrated filtrate was allowed to cool, white crystals gradually precipitated. The solution was cooled to 50 ° C. and filtered to obtain 85.0 g of white crystals. The obtained white crystals were analyzed by HPLC and found to be a mixture containing 88.4 area% of the main component. The total amount of this mixture (white crystals) was dissolved in 420 g of N, N-dimethylformamide and recrystallized to obtain 56.0 g of white crystals. The purity of the obtained white crystals analyzed by HPLC (based on the area of the area) was 100.0%, and the yield from NBDA was 9.0%. Moreover, the 13 C-NMR chart of the obtained white crystal is shown in FIG. From the 13 C-NMR chart shown in FIG. 5, the obtained white crystals were 2-endo-5-exo-bisphthalimidomethyl-bicyclo [2,2,1] heptane represented by the formula (II-1). It turned out to be.

(4)脱保護:
撹拌装置、温度計、温度計、窒素導入管、及びコンデンサーを備え付けた1000mlガラス製反応装置に、上記(3)の操作を繰り返し行って得られた2−endo−5−exo−ビスフタルイミドメチル−ビシクロ[2,2,1]ヘプタン124.4g(0.3mol)及びイソプロピルアルコール1000gを装入し、撹拌しながら60℃まで加熱した。同温度を維持しながら96%ヒドラジン(1水和物)90.1g(1.8mol)を1時間かけて滴下した。同温度を維持しながら更に3時間撹拌して反応を完結させた。なお、HPLCで2−endo−5−exo−ビスフタルイミドメチル−ビシクロ[2,2,1]ヘプタンの消失を確認することにより、反応の完結(終点)を確認した。反応終了後、室温まで冷却し、析出したフタラジンジオンを濾別した。また、目的物である2−endo−5−exo−NBDAが濾液中に存在していることをガスクロマトグラフィーによりで分析することにより確認した。なお、フタルイミド基を脱保護する際の反応式を以下に示す。
(4) Deprotection:
2-endo-5-exo-bisphthalimidomethyl- obtained by repeating the above operation (3) in a 1000 ml glass reactor equipped with a stirrer, thermometer, thermometer, nitrogen inlet tube and condenser. 124.4 g (0.3 mol) of bicyclo [2,2,1] heptane and 1000 g of isopropyl alcohol were charged and heated to 60 ° C. with stirring. While maintaining the same temperature, 90.1 g (1.8 mol) of 96% hydrazine (monohydrate) was added dropwise over 1 hour. The mixture was further stirred for 3 hours while maintaining the same temperature to complete the reaction. The completion (end point) of the reaction was confirmed by confirming the disappearance of 2-endo-5-exo-bisphthalimidomethyl-bicyclo [2,2,1] heptane by HPLC. After completion of the reaction, the reaction mixture was cooled to room temperature, and the precipitated phthalazinedione was separated by filtration. Moreover, it confirmed by analyzing by gas chromatography that the target object 2-endo-5-exo-NBDA was present in the filtrate. The reaction formula for deprotecting the phthalimide group is shown below.

Figure 2011201787
Figure 2011201787

ロータリーエバポレーターを使用して濾液を濃縮し、少量の溶媒及びヒドラジンを含む41.9gの淡黄色液体を得た。得られた液体について170〜175℃に加熱された油浴中、2.8〜3.5kPaの減圧度で減圧蒸留を行ったところ、無色透明の2−endo−5−exo−NBDA35.7gを得た。ガスクロマトグラフィーにより分析した2−endo−5−exo−NBDAの純度は100%であり、2−endo−5−exo−ビスフタルイミドメチル−ビシクロ[2,2,1]ヘプタンからの収率は77.2%であった。また、DSCにより融点を測定しようとしたところ−20℃においても結晶化しなかった。得られた2−endo−5−exo−NBDAの13C−NMRチャートを図6に示す。また、得られた2−endo−5−exo−NBDAのガスクロマトグラフィー(GC)チャートを図7に示す。 The filtrate was concentrated using a rotary evaporator to give 41.9 g of a pale yellow liquid containing a small amount of solvent and hydrazine. When the obtained liquid was subjected to vacuum distillation at a reduced pressure of 2.8 to 3.5 kPa in an oil bath heated to 170 to 175 ° C., 35.7 g of colorless and transparent 2-endo-5-exo-NBDA was obtained. Obtained. The purity of 2-endo-5-exo-NBDA analyzed by gas chromatography was 100%, and the yield from 2-endo-5-exo-bisphthalimidomethyl-bicyclo [2,2,1] heptane was 77%. 2%. Further, when the melting point was measured by DSC, it did not crystallize even at -20 ° C. FIG. 6 shows a 13 C-NMR chart of the obtained 2-endo-5-exo-NBDA. Moreover, the gas chromatography (GC) chart of obtained 2-endo-5-exo-NBDA is shown in FIG.

本発明の2,5−ジアミノメチル−ビシクロ[2,2,1]ヘプタンは、ポリイミド、エポキシ樹脂、ウレタン樹脂、及びポリイソシアネート等の原料として有用であり、特に、電子部品の構成材料として用いられるポリイミドフィルムを形成するための原料として好適である。
The 2,5-diaminomethyl-bicyclo [2,2,1] heptane of the present invention is useful as a raw material for polyimides, epoxy resins, urethane resins, polyisocyanates, and the like, and is particularly used as a constituent material for electronic components. It is suitable as a raw material for forming a polyimide film.

Claims (3)

下記式(I)又は(II)で表される、ガスクロマトグラフィーにより分析される純度が95%以上である2,5−ジアミノメチル−ビシクロ[2,2,1]ヘプタン。
Figure 2011201787
2,5-Diaminomethyl-bicyclo [2,2,1] heptane represented by the following formula (I) or (II) and having a purity analyzed by gas chromatography of 95% or more.
Figure 2011201787
下記式(I)で表される化合物、下記式(II)で表される化合物、下記式(III)で表される化合物、及び下記式(IV)で表される化合物を含むジアミノメチル−ビシクロ[2,2,1]ヘプタンの異性体混合物に含まれるそれぞれの化合物のアミノ基を保護基で保護した後、
下記式(I)又は(II)で表される化合物に由来する異性体を結晶化と固液分離を含む分離操作により分離し、次いで
分離した前記異性体の前記保護基を脱保護することを含む、下記式(I)又は(II)で表される、ガスクロマトグラフィーにより分析される純度が95%以上である2,5−ジアミノメチル−ビシクロ[2,2,1]ヘプタンの製造方法。
Figure 2011201787
Diaminomethyl-bicyclo containing a compound represented by the following formula (I), a compound represented by the following formula (II), a compound represented by the following formula (III), and a compound represented by the following formula (IV) After protecting the amino group of each compound contained in the isomer mixture of [2,2,1] heptane with a protecting group,
Separating an isomer derived from a compound represented by the following formula (I) or (II) by a separation operation including crystallization and solid-liquid separation, and then deprotecting the protecting group of the separated isomer. A method for producing 2,5-diaminomethyl-bicyclo [2,2,1] heptane represented by the following formula (I) or (II) and having a purity analyzed by gas chromatography of 95% or more.
Figure 2011201787
前記保護基が、フタルイミド基、t−ブチルオキシカルボニル基、又はベンジルオキシカルボニル基である、請求項2に記載の製造方法。   The production method according to claim 2, wherein the protecting group is a phthalimide group, a t-butyloxycarbonyl group, or a benzyloxycarbonyl group.
JP2010068199A 2010-03-24 2010-03-24 Process for producing 2,5-diaminomethyl-bicyclo [2,2,1] heptane Active JP5603627B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2010068199A JP5603627B2 (en) 2010-03-24 2010-03-24 Process for producing 2,5-diaminomethyl-bicyclo [2,2,1] heptane

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2010068199A JP5603627B2 (en) 2010-03-24 2010-03-24 Process for producing 2,5-diaminomethyl-bicyclo [2,2,1] heptane

Publications (2)

Publication Number Publication Date
JP2011201787A true JP2011201787A (en) 2011-10-13
JP5603627B2 JP5603627B2 (en) 2014-10-08

Family

ID=44878856

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010068199A Active JP5603627B2 (en) 2010-03-24 2010-03-24 Process for producing 2,5-diaminomethyl-bicyclo [2,2,1] heptane

Country Status (1)

Country Link
JP (1) JP5603627B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011201952A (en) * 2010-03-24 2011-10-13 Mitsui Chemicals Inc Polyimide, process for producing the same, polyamic acid and process for producing the same

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002010253A1 (en) * 2000-07-27 2002-02-07 Mitsui Chemicals, Inc. Polyamic acid, polyimide, process for producing these, and film of the polyimide

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002010253A1 (en) * 2000-07-27 2002-02-07 Mitsui Chemicals, Inc. Polyamic acid, polyimide, process for producing these, and film of the polyimide

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
JPN6014003142; ACS Symposium Series Vol.978, p.277-286 (2008). *
JPN6014003144; High Performance Polymers Vol.11, No.4, p.367-377 (1999). *
JPN6014003146; 高分子論文集 Vol.61, No.1, p.39-48 (2004). *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011201952A (en) * 2010-03-24 2011-10-13 Mitsui Chemicals Inc Polyimide, process for producing the same, polyamic acid and process for producing the same

Also Published As

Publication number Publication date
JP5603627B2 (en) 2014-10-08

Similar Documents

Publication Publication Date Title
WO2018183656A1 (en) Crystal form of 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1h-1,2,4-triazol-3-yl)phenyl)amino)-n-(methyl-d3) pyridazine-3-carboxamide
TWI386385B (en) New process for the synthesis of agomelatine
WO1998058901A1 (en) 3-anilino-2-cycloalkenone derivates
CN110831932A (en) Crystalline forms of N- [1- (5-cyano-pyridin-2-ylmethyl) -1H-pyrazol-3-yl ] -2- [4- (1-trifluoromethyl-cyclopropyl) -phenyl ] -acetamide
JP2005507900A (en) Citalopram manufacturing method
JP3450389B2 (en) Method for producing L-5- (2-acetoxy-propionylamino) -2,4,6-triiodo-isophthalic dichloride
JP5731256B2 (en) Crystal polymorph of 6,6- (9-fluorenylidene) -di (2-naphthol) and method for producing the same
JP5603627B2 (en) Process for producing 2,5-diaminomethyl-bicyclo [2,2,1] heptane
US10501403B2 (en) Method for preparation of (S)-N1-(2-aminoethyl)-3-(4-alkoxyphenyl)propane-1,2-diamine trihydrochloride
US6803489B2 (en) Purification process of fluorenylidenediallylphenol
WO2007080470A2 (en) A method for the purification of levetiracetam
EP2197273B1 (en) Process for preparing r-gossypol l-phenylalaninol dienamine
JP5603626B2 (en) Process for producing 2-endo-6-exo-diaminomethyl-bicyclo [2,2,1] heptane
CN100548981C (en) The method of the phthalic imidine that preparation N-replaces
CN108203396B (en) Synthesis of enkephalinase inhibitor
JP2019043941A (en) Carbazole derivative and biphenyl derivative production method and novel biphenyl derivative
CN110903254A (en) Synthetic method of heterocyclic intermediate applied to JAK inhibitor drugs
AU2022203495B2 (en) Method for preparing single isomer of 1-(1-(2- benzylphenoxy)propan-2-yl)-2-methylpiperidine in high-purity
JP3148556B2 (en) Method for producing 2-bisarylamino-9,9-dialkylfluorene
RU2227141C2 (en) Method for preparing benzylamine
WO2023100110A1 (en) Process for preparing brivaracetam
JP2009520753A (en) Process for the production of pure form of α-chiral chloromethyl compounds
WO2023230236A1 (en) Process for preparing jak inhibitors and intermediates thereof
JPH0411544B2 (en)
JP2022140107A (en) Method for producing 1,4-benzodiazepine compound

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20121112

RD05 Notification of revocation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7425

Effective date: 20131111

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140128

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140327

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20140812

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20140822

R150 Certificate of patent or registration of utility model

Ref document number: 5603627

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250